Valuation: ArcticZymes Technologies ASA

Market Cap 996M 104M 90.44M 84.68M 77.46M 146M 9.93B 148M 991M 389M 4.96B 391M 383M 16.51B P/E 2026 *
60.9x
P/E 2027 * 35.6x
Enterprise Value 707M 73.96M 64.19M 60.1M 54.98M 104M 7.05B 105M 703M 276M 3.52B 278M 272M 11.72B EV / Sales 2026 *
5.05x
EV / Sales 2027 * 4.21x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 day+1.03%
1 week+0.51%
Current month+0.51%
1 month+2.87%
3 months-2.48%
6 months-8.37%
Current year-4.37%
1 week 19
Extreme 19
19.9
1 month 18.35
Extreme 18.35
20.2
Current year 18.3
Extreme 18.3
26.6
1 year 18.3
Extreme 18.3
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
107.3
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 2023-09-17
Director of Finance/CFO 51 2014-09-30
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 2024-06-25
Director/Board Member 62 2024-06-25
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
8/14/25 Buy

Director

2,852 0.0056%
6/4/25 Buy

Chief Operating Officer

3,400 0.0067%
5/14/25 Fiscal year

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%+0.51%0.00%-45.95% 104M
+1.89%+3.20%+59.70%+165.18% 1,062B
-0.24%+0.45%+50.64%+52.02% 619B
-0.95%-5.26%+24.23%+65.08% 431B
+2.32%+5.40%+49.62%+40.72% 358B
+1.33%+0.14%+36.25%+41.10% 293B
+1.39%-4.91%+9.70%+10.34% 247B
-0.73%+4.44%+42.22%+66.41% 219B
+3.82%-0.34%-1.10%-44.03% 200B
-0.68%-0.32%+18.66%+66.32% 162B
Average +1.03%-1.71%+28.99%+41.72% 359.24B
Weighted average by Cap. +0.78%-0.83%+41.22%+78.34%

Financials

2026 *2027 *
Net sales 140M 14.64M 12.71M 11.9M 10.88M 20.55M 1.39B 20.82M 139M 54.63M 697M 54.98M 53.78M 2.32B 161M 16.83M 14.6M 13.67M 12.51M 23.61M 1.6B 23.92M 160M 62.78M 801M 63.18M 61.8M 2.67B
Net income 16.34M 1.71M 1.48M 1.39M 1.27M 2.4M 163M 2.43M 16.26M 6.38M 81.39M 6.42M 6.28M 271M 27.99M 2.93M 2.54M 2.38M 2.18M 4.11M 279M 4.16M 27.84M 10.93M 139M 11M 10.76M 464M
Net Debt -289M -30.25M -26.25M -24.58M -22.49M -42.45M -2.88B -43M -288M -113M -1.44B -114M -111M -4.79B -319M -33.4M -28.99M -27.14M -24.83M -46.87M -3.18B -47.48M -318M -125M -1.59B -125M -123M -5.29B
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
26-08-07 NOK 19.70 +1.03% 21,005
26-08-06 NOK 19.50 0.00% 5,839
26-08-05 NOK 19.50 -0.76% 10,455
26-08-04 NOK 19.65 +0.77% 21,393
26-08-03 NOK 19.50 -0.51% 21,873
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
19.50NOK
Average target price
28.00NOK
Spread / Average Target
+43.59%

Quarterly revenue - Rate of surprise